Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Pegylated Doxorubicin vs Doxorubicin in Elderly ALL Induction
NCT00600977Phase 2Completed
- Sponsor
- French Innovative Leukemia Organisation
- Start
- Mar 2002
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in acute lymphoblastic leukemia (ALL), sponsored by French Innovative Leukemia Organisation. Started Mar 2002; status: completed.
02
Drugs
doxorubicin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00600977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00600977.